TuisH5P • FRA
add
Hikma Pharmaceuticals Plc
Vorige sluiting
€23,80
Dagwisseling
€23,80 - €23,80
Jaarwisseling
€20,60 - €28,40
Markkapitalisasie
4,47 mjd GBP
Gemiddelde volume
4,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
LON
Marknuus
MarketWatch
9 uur gelede
U.S. stocks remain lower in midday trading, as Palantir weighs on the S&P 500
0,49%
12,14%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 779,00 m | 7,60% |
Bedryfskoste | 226,50 m | 20,48% |
Netto inkomste | 66,50 m | 125,42% |
Netto winsgrens | 8,54 | 109,83% |
Wins per aandeel | — | — |
EBITDA | 144,00 m | -17,95% |
Effektiewe belastingkoers | 20,36% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 213,00 m | -6,99% |
Totale bates | 5,13 mjd | 9,68% |
Totale aanspreeklikheid | 2,81 mjd | 13,80% |
Totale ekwiteit | 2,32 mjd | — |
Uitstaande aandele | 220,43 m | — |
Prys om te bespreek | 2,27 | — |
Opbrengs op bates | 5,02% | — |
Opbrengs op kapitaal | 7,10% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 66,50 m | 125,42% |
Kontant van bedrywe | 183,00 m | -5,18% |
Kontant van beleggings | -137,50 m | -28,50% |
Kontant van finansiering | -68,00 m | 43,10% |
Netto kontantverandering | -24,00 m | 28,36% |
Beskikbare kontantvloei | 44,69 m | -41,73% |
Meer oor
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Gestig
1978
Webwerf
Werknemers
9 500
